Monday 22 December 2025 ,
Monday 22 December 2025 ,
Latest News
From the Editor
Guillen Barre Syndrome (GBS) is a form of polyneuropathy that produces rapidly worsening muscle weakness, sometimes leading to paralysis. It is also known…
We cured your mother's cancer, but your love fixed her broken heart
This Christmas I’d like to write a letter to the daughter of one of my patients – because I could cure her mother’s cancer but only…
What is Guillain-Barr� Syndrome?
Guillain-Barré Syndrome (GBS) is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms…
GBS
What is Guillain-Barré syndrome (GBS)? Guillain-Barré syndrome is a problem with your nervous system. It causes muscle weakness, loss…
A patient with Guillain Barre Syndrome
A 32-year-old gentleman presented with a history of breathlessness. He had a past history of bronchiectasis. Examination revealed left sided coarse creptitation.…
Polio in Bangladesh
Dr Wrishi Raphael Bangladesh along with 10 other countries of WHO South-East Asia Region was certified polio-free in 2014 by an independent commission…
New report signals country progress in the path to malaria elimination
New estimates from WHO show a significant increase in the number of countries moving towards malaria elimination, with prevention efforts saving millions…
6 Foods that balance your hormones naturally for younger-looking skin
Celia Shatzman When you belly up to the salad bar or roll through the grocery store, you're up against a battery of decisions: Which leafy green is…
Skin-to-skin contact may lower preemies' risk of death: review
Tiny newborns who get prolonged skin-to-skin contact with mom while they're in the hospital may have better survival odds, a new review finds. Experts…
Novo Nordisk supported organising changing diabetes� in children camp to develop confidence of children living with diabetes
Recently Novo Nordisk has supported to organise a camp for children living with diabetes to develop confidence and knowledge for better management of…
FDA approves Bridion (sugammadex) to reverse effects of neuromuscular blocking drugs
The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium…
FDA approves Alecensa
The U.S. Food and Drug Administration has approved Alecensa (alectinib), an oral anaplastic lymphoma kinase (ALK) inhibitor for the treatment of people…
Most Viewed
- What is Guillain-Barr� Syndrome?
- Gentle Park brings winter collection
- Raka Biswas begins acting journey
- FDA approves Alecensa
- Polio in Bangladesh
- 1971 Indo-Pak war: Reflections on international relations and Indian leadership
- Nasir U Mahmud reelected Uttara Club president
- GBS
- Bappa Raj to play negative role in �Missed Call�
- �Grade inflation� casts doubt on edn quality
Digital Edition
Copyright © All right reserved.
Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.
Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.
Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription
Powered by : Frog Hosting
